Inhibrx Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Inhibrx
INBX Stock  USD 14.00  0.06  0.43%   
Inhibrx financial statements provide useful quarterly and yearly information to potential Inhibrx investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Inhibrx financial statements helps investors assess Inhibrx's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Inhibrx's valuation are summarized below:
Gross Profit
-189.4 M
Profit Margin
1.1 K
Market Capitalization
201.8 M
Enterprise Value Revenue
4.6538
Revenue
1.6 M
We have found one hundred twenty available fundamental trends for Inhibrx, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Inhibrx regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road.

Inhibrx Total Revenue

190,000

Check Inhibrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx's main balance sheet or income statement drivers, such as Minority Interest of 0.0, Tax Provision of 2.6 K or Depreciation And Amortization of 1.1 M, as well as many indicators such as Price To Sales Ratio of 1.2 K, Dividend Yield of 0.0021 or PTB Ratio of 1.79. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Valuation or Volatility modules.
  
Check out the analysis of Inhibrx Correlation against competitors.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

Inhibrx Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Current Liabilities31.4 M29.9 M9.6 M
Slightly volatile
Total Current Liabilities28 M40.7 M18.1 M
Slightly volatile
Other Liabilities120.2 K126.5 K351.1 K
Pretty Stable
Accounts Payable7.2 M9.2 M4.2 M
Slightly volatile
Other Current Assets7 M7.4 M11.3 M
Pretty Stable
Total Current Assets130.1 M160.4 M82.3 M
Slightly volatile
Property Plant Equipment2.7 M2.9 M3.3 M
Slightly volatile
Total Assets155 M180.8 M87.7 M
Slightly volatile
Short and Long Term Debt Total7.6 M8 M44.2 M
Slightly volatile
Property Plant And Equipment Net9.1 M13.5 M5.5 M
Slightly volatile
Current Deferred Revenue141.9 K149.4 K2.3 M
Slightly volatile
Cash136.3 M152.6 M76.4 M
Slightly volatile
Non Current Assets Total11.4 M20.4 M6.7 M
Slightly volatile
Long Term Debt249.9 M238 M69.2 M
Slightly volatile
Cash And Short Term Investments136.3 M152.6 M76.4 M
Slightly volatile
Net Receivables474.9 K397 K631 K
Slightly volatile
Common Stock Shares Outstanding14.2 M15 M29.6 M
Very volatile
Liabilities And Stockholders Equity155 M180.8 M87.7 M
Slightly volatile
Non Current Liabilities Total6.1 M6.5 M58.5 M
Slightly volatile
Total Liabilities44.8 M47.2 M78.8 M
Slightly volatile
Property Plant And Equipment Gross19.4 M18.5 M6.2 M
Slightly volatile
Short and Long Term Debt3.9 M3.2 M4.5 M
Slightly volatile
Non Current Liabilities Other2 M3.6 M1.2 M
Slightly volatile
Short Term Debt2.7 M1.6 M4.1 M
Slightly volatile
Non Currrent Assets Other7.2 M6.8 M2.4 M
Slightly volatile
Other Assets1.091.151.3 M
Slightly volatile
Common Stock Total Equity3.7 K4.6 K3.3 K
Slightly volatile
Deferred Long Term Liabilities1.4 M1.6 M1.7 M
Slightly volatile
Capital Stock4 K5.8 K3.5 K
Slightly volatile
Common Stock95010003 K
Pretty Stable
Long Term Debt Total244 M232.4 M79.5 M
Slightly volatile
Capital Surpluse341.3 M495 M275.4 M
Slightly volatile

Inhibrx Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision2.6 K2.7 K188.1 K
Slightly volatile
Depreciation And Amortization1.1 M1.4 M753 K
Slightly volatile
Selling General Administrative134.3 M127.9 M22.9 M
Slightly volatile
Total Revenue190 K200 K6.5 M
Slightly volatile
Other Operating Expenses348.2 M331.6 M94.2 M
Slightly volatile
Research Development104 M203.7 M64.9 M
Slightly volatile
Cost Of Revenue1 M1.1 M23 M
Slightly volatile
Total Operating Expenses348.2 M331.6 M94.1 M
Slightly volatile
Reconciled Depreciation1.1 M1.4 M757.4 K
Slightly volatile
Income Tax Expense1.9 K2 K188.1 K
Slightly volatile
Non Operating Income Net Other8559001.5 M
Slightly volatile
Interest Income7.7 M13.7 M3.8 M
Slightly volatile
Selling And Marketing Expenses159.2 K179.1 K195.3 K
Slightly volatile

Inhibrx Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation61.4 M58.5 M12.1 M
Slightly volatile
Begin Period Cash Flow291.8 M277.9 M76.1 M
Slightly volatile
Other Cashflows From Financing Activities91 M71.7 M57.9 M
Slightly volatile
Depreciation1.1 M2.3 M754.6 K
Slightly volatile
Capital Expenditures1.8 M2.6 M1.1 M
Slightly volatile
Total Cash From Financing Activities107.7 M71.7 M72.6 M
Slightly volatile
End Period Cash Flow123.6 M152.6 M78.5 M
Slightly volatile
Issuance Of Capital Stock241.5 M230 M73.3 M
Slightly volatile
Sale Purchase Of Stock82.8 M116.8 M125.5 M
Slightly volatile
Cash And Cash Equivalents Changes96.2 M163.9 M114.8 M
Very volatile
Other Cashflows From Investing Activities44 K49.5 K54 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.2 K1.1 K319
Slightly volatile
Dividend Yield0.00210.00170.002
Slightly volatile
Days Sales Outstanding761725128
Slightly volatile
Stock Based Compensation To Revenue30729339.1114
Slightly volatile
Capex To Depreciation1.891.13651.4051
Slightly volatile
EV To Sales216417208
Slightly volatile
Payables Turnover0.160.143348.2833
Slightly volatile
Sales General And Administrative To Revenue67264083.9479
Slightly volatile
Research And Ddevelopement To Revenue1.1 K1 K143
Slightly volatile
Capex To Revenue13.6312.9851.9058
Slightly volatile
Cash Per Share10.8210.30912.9436
Slightly volatile
Days Payables Outstanding2.4 K2.3 K578
Slightly volatile
Current Ratio3.243.93813.9308
Pretty Stable
Receivables Turnover0.480.503810.2326
Slightly volatile
Graham Number122137149
Slightly volatile
Capex Per Share0.180.17540.046
Slightly volatile
Revenue Per Share0.01280.01350.1807
Slightly volatile
Debt To Assets0.04230.04450.7372
Slightly volatile
Days Of Payables Outstanding2.4 K2.3 K578
Slightly volatile
Quick Ratio3.583.93814.1867
Pretty Stable
Net Income Per E B T0.761.00.8235
Slightly volatile
Cash Ratio3.073.74653.7736
Pretty Stable
Days Of Sales Outstanding761725128
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.01341.0303
Slightly volatile
Fixed Asset Turnover0.0140.01484.0355
Slightly volatile
Debt Ratio0.04230.04450.7372
Slightly volatile
Price Sales Ratio1.2 K1.1 K319
Slightly volatile
Asset Turnover0.00110.00110.2438
Slightly volatile

Inhibrx Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap603.3 M678.7 M740 M
Slightly volatile
Enterprise Value614.9 M705.9 M755.1 M
Pretty Stable

Inhibrx Fundamental Market Drivers

Cash And Short Term Investments152.6 M

Inhibrx Upcoming Events

4th of March 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Inhibrx Financial Statements

Inhibrx investors use historical fundamental indicators, such as Inhibrx's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Inhibrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue149.4 K141.9 K
Total Revenue200 K190 K
Cost Of Revenue1.1 M1 M
Stock Based Compensation To Revenue 292.59  307.22 
Sales General And Administrative To Revenue 639.53  671.50 
Research And Ddevelopement To Revenue1 K1.1 K
Capex To Revenue 12.99  13.63 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue-1.7 K-1.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY